Updated:
Emerge Ventures
Emerge Ventures operates as an early-stage venture capital firm based in Tel Aviv.
Emerge Ventures
Emerge Ventures operates as an early-stage venture capital firm based in Tel Aviv. The firm partners with technology innovators at the seed stage, offering capital and operational support from its office in the HaArba'a Street north tower. Its outreach email, hi@emerge.ventures, signals a deliberately flat structure. Emerge deploys capital into nascent technology companies, with a disclosed portfolio spanning eight stealth-mode startups. The portfolio is tagged across enterprise software, fintech, healthcare, biotech, consumer research, agentic commerce, and logistics. The firm's public posture indicates a single-office strategy focused on Israel. No data on team size, total deployment, or specific fund vehicles was verifiable from public sources. The firm's website lists only two first names — Dovi and Liad — without full surnames, titles, or professional biographies. No dated operational event from the last 24 months was identifiable. Emerge's structural distinction lies in its concentrated, label-resistant approach: a portfolio composed entirely of companies still in stealth. This suggests a sourcing model built on deep founder relationships and early technical conviction rather than on marketed deal flow or multi-stage portfolio construction.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
Middle East
Country
Israel
City
Tel Aviv
Corporate office
28th HaArba'a St. 11th floor, North Tower, Tel Aviv, Israel
Sector focus
Frequently asked questions
Who runs investment decisions at Emerge Ventures?
The names Dovi and Liad appear on the firm's contact page, suggesting they are central to operations and investment decisions. No full names, titles, or professional biographies are publicly available to delineate specific roles or any investment committee structure.
What investment stage does Emerge Ventures typically target?
The firm states it is early-stage and partners with founders at the seed stage. No later-stage or growth-equity investment activity is indicated by its current public materials.
Which sectors does Emerge Ventures concentrate on?
Emerge's disclosed portfolio focuses on enterprise software, fintech, healthcare, biotech, logistics, and agentic commerce. The firm appears to avoid publicly announcing sector-avoidance criteria.
Is all of Emerge's current portfolio still in stealth?
Yes. All eight portfolio companies listed on the firm's website are labeled as 'Stealth,' covering categories from enterprise software and fintech to biotech and a cancer-curing effort. No publicly named portfolio companies are available.
How does Emerge Ventures source proprietary deal flow?
The firm's operational model, built entirely on stealth-stage companies, implies deal flow sourced through close-knit founder networks within Israel. There is no indication of a public application process or marketed co-investor syndication.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: